Antibiotics May Prevent Chemoresistance in Metastatic Pancreatic Cancer
Antibiotics may prevent bacteria-mediated chemoresistance in patients with metastatic pancreatic cancer, a new study suggests.
Diagnosis & Disease Information
Ulenistamab Fast Tracked for Advanced/Metastatic Pancreatic Cancer
Ulenistamab targets PAUF, a tumor-specific protein that is overexpressed in pancreatic cancer cells.
Ramucirumab Does Not Improve Upon Chemotherapy in Advanced Pancreatic Cancer
Adding ramucirumab to first-line chemotherapy does not improve outcomes in patients with advanced pancreatic ductal adenocarcinoma, a study suggests.
Cancer Patients in Nursing Homes More Likely to Receive Aggressive End-of-Life Care
Cancer patients living in nursing homes are more likely to receive aggressive end-of-life care and die in the hospital, a study suggests.
Pancreatic Cancer Trials Don’t Adhere to Eligibility Criteria Guidelines
Overall compliance with eligibility criteria guidelines is low for pancreatic cancer trials, a recent study suggests.
Incidence of Pancreatic Cancer Increasing in Younger Women
In younger adults, there was a greater increase in the incidence of pancreatic cancer among women than among men.
Cancer Mortality Rates Increased for Older Patients With Diabetes
People with type 2 diabetes have an increased risk of death from colorectal, pancreatic, liver, and endometrial cancer, compared with the general population.
System May Enable Precision Medicine in Cancer Care
A decision support system called GI TARGET may help integrate precision medicine into routine care for patients with gastrointestinal cancer, according to researchers.
NAPOLI-3 Results Support NALIRIFOX for Metastatic Pancreatic Cancer
NALIRIFOX outperformed treatment with nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer in the NAPOLI-3 trial.
ACS Report Shows Prostate Cancer on the Rise, Cervical Cancer on the Decline
A report from the American Cancer Society reveals trends in cancer incidence and mortality over time and includes projections for 2023.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...